Monitoring T-cell responses in a phase II study of AGS-003, an autologous dendritic cell-based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback